Endocrine Testing Product Market, by Product Type (Instruments/Analyzers and Consumables), by Technology (Liquid Chromatography-Mass Spectrometry, Immunoassay, Monoclonal and Polyclonal Antibody, Electrochemical/Biosensor (Sensor), and Clinical Chemistry)

Endocrine Testing Product Market, by Product Type (Instruments/Analyzers and Consumables), by Technology (Liquid Chromatography-Mass Spectrometry, Immunoassay, Monoclonal and Polyclonal Antibody, Electrochemical/Biosensor (Sensor), and Clinical Chemistry), by Test Type (Adrenocorticotropic Hormone (ACTH), Calcitonin, Calcium, Cortisol, Catecholamine, Dehydroepiandrosterone Sulfate (DHEA-S), Estradiol, Follicle Stimulating Hormone, Growth Hormone, Luteinizing Hormone, Prolactin, Progesterone, Testosterone, Thyroid Stimulating Hormone, Vitamin D, and Others), by Disease Indication (Adrenal Insufficiency and Addison Disease, Bone Disorders, Cancer (Tumor), Infertility, Renal Diseases, Metabolic (Including Diabetes) and Gastrointestinal Disorders, Pituitary Disorders, Thyroid Disease, and Others), by End User (Hospitals & Clinics, Diagnostic Laboratories, Satellite Laboratories, Commercial Labs, Home Care Settings, and Ambulatory Care Centers) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Endocrine testing includes diagnosis of endocrine related disorders such as infertility, diabetes, and thyroid related disorders. The diagnosis of various endocrine system disorders are determined by evaluating different endocrine hormone levels in the blood. The global endocrine testing market is expected to witness significant growth, owing to increasing incidence of lifestyle disorders such as hypothyroidism, hyperthyroidism, infertility, and diabetes. For instance, according to American Thyroid Association report 2017, the U.S. performs approximately 15% to 30% thyroid fine needle aspiration (FNA) on an annual basis.
Market Dynamics
Market players are engaged in launching new products for endocrine testing products, this is expected to increase the growth of the global endocrine testing products, over the forecast period. For instance, in July 2018, Ortho Clinical Diagnostics launched VITROS XT 7600 Integrated System, at the 2018 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo, held in U.S. It has applications in cardiology, infectious diseases, and endocrinology.
Key players are focusing on inorganic activities such as partnerships, this is expected to increase the growth of the global endocrine testing products market, over the forecast period. For instance, in 2020, Hackensack Meridian Health, an integrated health care network in New Jersey, U.S. and Quest Diagnostics, entered into a partnership, in order to increase the quality and value of diagnostic services provided to patients and their doctors. Under the partnership agreement, Quest Diagnostics will look after all the laboratory operations and also perform reference testing for around 11 Hackensack Meridian Health hospitals under the long-term full laboratory management partnership agreement.
Moreover, in 2016, Sysmex Corporation and Siemens Healthcare Laboratory Diagnostics extended their partnership through the year 2020. Both the companies are indulged in supply, distributorship, and sales and partnership agreement for hemostasis products including analyzers.
Key features of the study:
This report provides an in-depth analysis of the global endocrine testing products market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global endocrine testing products market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include F. Hoffmann-la Roche Ag, Abbott Laboratories, Agilent Technologies, BioMerieux S.A., Bio-Rad Laboratories, Inc., Siemens Healthineers, Danaher Corporation, DiaSorin S.p.A., Immunodiagnostic Systems, Laboratory Corporation of America Holdings (LabCorp), Fujirebio, Inc., Thermo Fisher Scientific Inc., Quest Diagnostics, Sysmex Corporation, MP Biomedicals, Ortho Clinical Diagnostics, and Meridian Life Science, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global endocrine testing products market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine testing products market
Detailed Segmentation:
Global Endocrine Testing Products Market, By Product Type:
Instruments/Analyzers
Consumables
Global Endocrine Testing Products Market, By Technology:
Liquid Chromatography-Mass Spectrometry
Immunoassay
Monoclonal and Polyclonal Antibody
Electrochemical/Biosensor (Sensor)
Clinical Chemistry
Global Endocrine Testing Products Market, By Test Type:
Adrenocorticotropic Hormone (ACTH)
Calcitonin
Calcium
Cortisol
Catecholamine
Dehydroepiandrosterone Sulfate (DHEA-S)
Estradiol
Follicle Stimulating Hormone
Growth Hormone
Luteinizing Hormone
Prolactin
Progesterone
Testosterone
Thyroid Stimulating Hormone
Vitamin D
Others
Global Endocrine Testing Products Market, By Disease Indication:
Adrenal Insufficiency and Addison Disease
Bone Disorders
Cancer (Tumor)
Infertility
Renal Diseases
Metabolic (Including Diabetes) and Gastrointestinal Disorders
Pituitary Disorders
Thyroid Disease
Others
Global Endocrine Testing Products Market, By End User:
Hospitals & Clinics
Diagnostic Laboratories
Satellite Laboratories
Commercial Labs
Home Care Settings
Ambulatory Care Centers
Global Endocrine Testing Products Market, By Region:
North America
By Country:
U.S.
Canada
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Middle East
By Country:
GCC
Israel
Rest of Middle East
Africa
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Hoffmann-La Roche Ltd.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Abbott Laboratories
Agilent Technologies
BioMerieux S.A.
Bio-Rad Laboratories, Inc.
Siemens Healthineers
Danaher Corporation
DiaSorin S.p.A.
Immunodiagnostic Systems
Laboratory Corporation of America Holdings (LabCorp)
Fujirebio, Inc.
Thermo Fisher Scientific Inc.
Quest Diagnostics
Sysmex Corporation
MP Biomedicals
Ortho Clinical Diagnostics
Meridian Life Science, Inc.
“*” marked represents similar segmentation in other categories in the respective section.